nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—osteoarthritis—Methylprednisolone—rheumatoid arthritis	0.196	0.5	CpDpCtD
Sulindac—osteoarthritis—Prednisone—rheumatoid arthritis	0.196	0.5	CpDpCtD
Sulindac—PTGS2—rheumatoid arthritis	0.096	0.529	CbGaD
Sulindac—ALB—rheumatoid arthritis	0.0856	0.471	CbGaD
Sulindac—ALB—Auranofin—rheumatoid arthritis	0.0419	0.188	CbGbCtD
Sulindac—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0265	0.119	CbGbCtD
Sulindac—PTGS2—Triamcinolone—rheumatoid arthritis	0.0265	0.119	CbGbCtD
Sulindac—PTGS2—Betamethasone—rheumatoid arthritis	0.0227	0.102	CbGbCtD
Sulindac—PTGS1—Sulfasalazine—rheumatoid arthritis	0.0223	0.1	CbGbCtD
Sulindac—CYP1A2—Leflunomide—rheumatoid arthritis	0.0162	0.0724	CbGbCtD
Sulindac—SLC22A6—Cyclosporine—rheumatoid arthritis	0.0149	0.0665	CbGbCtD
Sulindac—ALB—Prednisone—rheumatoid arthritis	0.0133	0.0598	CbGbCtD
Sulindac—PTGS2—Dexamethasone—rheumatoid arthritis	0.0132	0.0592	CbGbCtD
Sulindac—CYP1A1—Dexamethasone—rheumatoid arthritis	0.0112	0.05	CbGbCtD
Sulindac—SLC22A6—Methotrexate—rheumatoid arthritis	0.00786	0.0352	CbGbCtD
Sulindac—ALB—Methotrexate—rheumatoid arthritis	0.00669	0.03	CbGbCtD
Sulindac—MAPK3—exocrine gland—rheumatoid arthritis	0.00203	0.0869	CbGeAlD
Sulindac—PTGDR2—tendon—rheumatoid arthritis	0.00166	0.0711	CbGeAlD
Sulindac—AKR1B1—parotid gland—rheumatoid arthritis	0.00146	0.0624	CbGeAlD
Sulindac—PTGS2—skeletal joint—rheumatoid arthritis	0.00144	0.0619	CbGeAlD
Sulindac—AKR1B1—saliva-secreting gland—rheumatoid arthritis	0.00139	0.0598	CbGeAlD
Sulindac—AKR1B1—connective tissue—rheumatoid arthritis	0.00128	0.055	CbGeAlD
Sulindac—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.0011	0.047	CbGeAlD
Sulindac—MAPK3—parotid gland—rheumatoid arthritis	0.00105	0.0453	CbGeAlD
Sulindac—MAPK3—saliva-secreting gland—rheumatoid arthritis	0.00101	0.0434	CbGeAlD
Sulindac—PTGS2—cartilage tissue—rheumatoid arthritis	0.000969	0.0416	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—rheumatoid arthritis	0.000936	0.0402	CbGeAlD
Sulindac—MAPK3—connective tissue—rheumatoid arthritis	0.000928	0.0398	CbGeAlD
Sulindac—AKR1B1—digestive system—rheumatoid arthritis	0.000925	0.0397	CbGeAlD
Sulindac—AKR1B1—tendon—rheumatoid arthritis	0.00088	0.0378	CbGeAlD
Sulindac—PPARD—lymphoid tissue—rheumatoid arthritis	0.000736	0.0316	CbGeAlD
Sulindac—PPARD—digestive system—rheumatoid arthritis	0.000727	0.0312	CbGeAlD
Sulindac—PPARD—tendon—rheumatoid arthritis	0.000692	0.0297	CbGeAlD
Sulindac—MAPK3—lymphoid tissue—rheumatoid arthritis	0.000679	0.0291	CbGeAlD
Sulindac—MAPK3—digestive system—rheumatoid arthritis	0.00067	0.0288	CbGeAlD
Sulindac—MAPK3—tendon—rheumatoid arthritis	0.000638	0.0274	CbGeAlD
Sulindac—CYP1A1—parotid gland—rheumatoid arthritis	0.000326	0.014	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000269	0.159	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000264	0.156	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000264	0.156	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000258	0.153	CbGdCrCtD
Sulindac—PTGS1—connective tissue—rheumatoid arthritis	0.000252	0.0108	CbGeAlD
Sulindac—PTGS2—connective tissue—rheumatoid arthritis	0.000241	0.0103	CbGeAlD
Sulindac—CYP1A2—digestive system—rheumatoid arthritis	0.00021	0.00902	CbGeAlD
Sulindac—CYP1A1—digestive system—rheumatoid arthritis	0.000207	0.0089	CbGeAlD
Sulindac—PTGS1—digestive system—rheumatoid arthritis	0.000182	0.00782	CbGeAlD
Sulindac—PTGS2—lymphoid tissue—rheumatoid arthritis	0.000176	0.00757	CbGeAlD
Sulindac—PTGS2—digestive system—rheumatoid arthritis	0.000174	0.00747	CbGeAlD
Sulindac—PTGS1—tendon—rheumatoid arthritis	0.000173	0.00744	CbGeAlD
Sulindac—PTGS2—tendon—rheumatoid arthritis	0.000166	0.00711	CbGeAlD
Sulindac—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000162	0.0958	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.00016	0.0943	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.00016	0.0943	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000156	0.0921	CbGdCrCtD
Sulindac—Syncope—Dexamethasone—rheumatoid arthritis	6.17e-05	0.000751	CcSEcCtD
Sulindac—Arrhythmia—Prednisone—rheumatoid arthritis	6.15e-05	0.000748	CcSEcCtD
Sulindac—Sweating—Methotrexate—rheumatoid arthritis	6.14e-05	0.000748	CcSEcCtD
Sulindac—Hypotension—Hydrocortisone—rheumatoid arthritis	6.14e-05	0.000747	CcSEcCtD
Sulindac—Haematuria—Methotrexate—rheumatoid arthritis	6.11e-05	0.000744	CcSEcCtD
Sulindac—Feeling abnormal—Cyclosporine—rheumatoid arthritis	6.09e-05	0.000742	CcSEcCtD
Sulindac—Vomiting—Leflunomide—rheumatoid arthritis	6.09e-05	0.000741	CcSEcCtD
Sulindac—Shock—Triamcinolone—rheumatoid arthritis	6.08e-05	0.000741	CcSEcCtD
Sulindac—Insomnia—Prednisolone—rheumatoid arthritis	6.08e-05	0.000741	CcSEcCtD
Sulindac—Alopecia—Prednisone—rheumatoid arthritis	6.08e-05	0.00074	CcSEcCtD
Sulindac—Shock—Methylprednisolone—rheumatoid arthritis	6.07e-05	0.000739	CcSEcCtD
Sulindac—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	6.04e-05	0.000736	CcSEcCtD
Sulindac—Loss of consciousness—Betamethasone—rheumatoid arthritis	6.04e-05	0.000736	CcSEcCtD
Sulindac—Loss of consciousness—Dexamethasone—rheumatoid arthritis	6.04e-05	0.000736	CcSEcCtD
Sulindac—Epistaxis—Methotrexate—rheumatoid arthritis	6.04e-05	0.000736	CcSEcCtD
Sulindac—Paraesthesia—Prednisolone—rheumatoid arthritis	6.04e-05	0.000735	CcSEcCtD
Sulindac—Rash—Leflunomide—rheumatoid arthritis	6.04e-05	0.000735	CcSEcCtD
Sulindac—Tachycardia—Triamcinolone—rheumatoid arthritis	6.04e-05	0.000735	CcSEcCtD
Sulindac—Dermatitis—Leflunomide—rheumatoid arthritis	6.03e-05	0.000735	CcSEcCtD
Sulindac—Nausea—Azathioprine—rheumatoid arthritis	6.02e-05	0.000734	CcSEcCtD
Sulindac—Tachycardia—Methylprednisolone—rheumatoid arthritis	6.02e-05	0.000733	CcSEcCtD
Sulindac—Headache—Leflunomide—rheumatoid arthritis	6e-05	0.000731	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	5.98e-05	0.000729	CcSEcCtD
Sulindac—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	5.98e-05	0.000728	CcSEcCtD
Sulindac—Agranulocytosis—Methotrexate—rheumatoid arthritis	5.98e-05	0.000728	CcSEcCtD
Sulindac—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	5.97e-05	0.000726	CcSEcCtD
Sulindac—Convulsion—Betamethasone—rheumatoid arthritis	5.96e-05	0.000726	CcSEcCtD
Sulindac—Convulsion—Dexamethasone—rheumatoid arthritis	5.96e-05	0.000726	CcSEcCtD
Sulindac—Insomnia—Hydrocortisone—rheumatoid arthritis	5.94e-05	0.000723	CcSEcCtD
Sulindac—Hypertension—Betamethasone—rheumatoid arthritis	5.94e-05	0.000723	CcSEcCtD
Sulindac—Hypertension—Dexamethasone—rheumatoid arthritis	5.94e-05	0.000723	CcSEcCtD
Sulindac—Paraesthesia—Hydrocortisone—rheumatoid arthritis	5.9e-05	0.000718	CcSEcCtD
Sulindac—Urticaria—Cyclosporine—rheumatoid arthritis	5.87e-05	0.000715	CcSEcCtD
Sulindac—Myalgia—Dexamethasone—rheumatoid arthritis	5.85e-05	0.000713	CcSEcCtD
Sulindac—Myalgia—Betamethasone—rheumatoid arthritis	5.85e-05	0.000713	CcSEcCtD
Sulindac—Body temperature increased—Cyclosporine—rheumatoid arthritis	5.84e-05	0.000712	CcSEcCtD
Sulindac—Discomfort—Betamethasone—rheumatoid arthritis	5.78e-05	0.000704	CcSEcCtD
Sulindac—Discomfort—Dexamethasone—rheumatoid arthritis	5.78e-05	0.000704	CcSEcCtD
Sulindac—Dyspepsia—Hydrocortisone—rheumatoid arthritis	5.78e-05	0.000704	CcSEcCtD
Sulindac—Hypotension—Methylprednisolone—rheumatoid arthritis	5.77e-05	0.000702	CcSEcCtD
Sulindac—Hepatitis—Methotrexate—rheumatoid arthritis	5.75e-05	0.0007	CcSEcCtD
Sulindac—Decreased appetite—Hydrocortisone—rheumatoid arthritis	5.71e-05	0.000695	CcSEcCtD
Sulindac—Nausea—Leflunomide—rheumatoid arthritis	5.69e-05	0.000693	CcSEcCtD
Sulindac—Fatigue—Hydrocortisone—rheumatoid arthritis	5.66e-05	0.00069	CcSEcCtD
Sulindac—Vision blurred—Prednisone—rheumatoid arthritis	5.64e-05	0.000687	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	5.63e-05	0.000686	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	5.62e-05	0.000685	CcSEcCtD
Sulindac—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	5.61e-05	0.000683	CcSEcCtD
Sulindac—Anaphylactic shock—Betamethasone—rheumatoid arthritis	5.61e-05	0.000683	CcSEcCtD
Sulindac—Oedema—Betamethasone—rheumatoid arthritis	5.61e-05	0.000683	CcSEcCtD
Sulindac—Oedema—Dexamethasone—rheumatoid arthritis	5.61e-05	0.000683	CcSEcCtD
Sulindac—Insomnia—Triamcinolone—rheumatoid arthritis	5.59e-05	0.000681	CcSEcCtD
Sulindac—Insomnia—Methylprednisolone—rheumatoid arthritis	5.58e-05	0.00068	CcSEcCtD
Sulindac—Ill-defined disorder—Prednisone—rheumatoid arthritis	5.56e-05	0.000677	CcSEcCtD
Sulindac—Paraesthesia—Triamcinolone—rheumatoid arthritis	5.55e-05	0.000676	CcSEcCtD
Sulindac—Feeling abnormal—Prednisolone—rheumatoid arthritis	5.54e-05	0.000675	CcSEcCtD
Sulindac—Paraesthesia—Methylprednisolone—rheumatoid arthritis	5.54e-05	0.000675	CcSEcCtD
Sulindac—Visual impairment—Methotrexate—rheumatoid arthritis	5.54e-05	0.000675	CcSEcCtD
Sulindac—Anaemia—Prednisone—rheumatoid arthritis	5.53e-05	0.000674	CcSEcCtD
Sulindac—Shock—Dexamethasone—rheumatoid arthritis	5.52e-05	0.000672	CcSEcCtD
Sulindac—Shock—Betamethasone—rheumatoid arthritis	5.52e-05	0.000672	CcSEcCtD
Sulindac—Dyspnoea—Triamcinolone—rheumatoid arthritis	5.51e-05	0.000671	CcSEcCtD
Sulindac—Thrombocytopenia—Betamethasone—rheumatoid arthritis	5.49e-05	0.000669	CcSEcCtD
Sulindac—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	5.49e-05	0.000669	CcSEcCtD
Sulindac—Tachycardia—Betamethasone—rheumatoid arthritis	5.48e-05	0.000667	CcSEcCtD
Sulindac—Tachycardia—Dexamethasone—rheumatoid arthritis	5.48e-05	0.000667	CcSEcCtD
Sulindac—Angioedema—Prednisone—rheumatoid arthritis	5.47e-05	0.000666	CcSEcCtD
Sulindac—Hypersensitivity—Cyclosporine—rheumatoid arthritis	5.45e-05	0.000663	CcSEcCtD
Sulindac—Dyspepsia—Triamcinolone—rheumatoid arthritis	5.44e-05	0.000663	CcSEcCtD
Sulindac—Erythema multiforme—Methotrexate—rheumatoid arthritis	5.44e-05	0.000662	CcSEcCtD
Sulindac—Dyspepsia—Methylprednisolone—rheumatoid arthritis	5.43e-05	0.000662	CcSEcCtD
Sulindac—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	5.43e-05	0.000661	CcSEcCtD
Sulindac—Hyperhidrosis—Betamethasone—rheumatoid arthritis	5.43e-05	0.000661	CcSEcCtD
Sulindac—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	5.41e-05	0.000659	CcSEcCtD
Sulindac—Malaise—Prednisone—rheumatoid arthritis	5.4e-05	0.000658	CcSEcCtD
Sulindac—Vertigo—Prednisone—rheumatoid arthritis	5.38e-05	0.000655	CcSEcCtD
Sulindac—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	5.37e-05	0.000654	CcSEcCtD
Sulindac—Syncope—Prednisone—rheumatoid arthritis	5.37e-05	0.000654	CcSEcCtD
Sulindac—Tinnitus—Methotrexate—rheumatoid arthritis	5.36e-05	0.000653	CcSEcCtD
Sulindac—Anorexia—Dexamethasone—rheumatoid arthritis	5.35e-05	0.000651	CcSEcCtD
Sulindac—Anorexia—Betamethasone—rheumatoid arthritis	5.35e-05	0.000651	CcSEcCtD
Sulindac—Urticaria—Prednisolone—rheumatoid arthritis	5.34e-05	0.000651	CcSEcCtD
Sulindac—Fatigue—Triamcinolone—rheumatoid arthritis	5.33e-05	0.000649	CcSEcCtD
Sulindac—Fatigue—Methylprednisolone—rheumatoid arthritis	5.32e-05	0.000648	CcSEcCtD
Sulindac—Asthenia—Cyclosporine—rheumatoid arthritis	5.3e-05	0.000646	CcSEcCtD
Sulindac—Loss of consciousness—Prednisone—rheumatoid arthritis	5.26e-05	0.000641	CcSEcCtD
Sulindac—Hypotension—Dexamethasone—rheumatoid arthritis	5.24e-05	0.000639	CcSEcCtD
Sulindac—Hypotension—Betamethasone—rheumatoid arthritis	5.24e-05	0.000639	CcSEcCtD
Sulindac—Pruritus—Cyclosporine—rheumatoid arthritis	5.23e-05	0.000637	CcSEcCtD
Sulindac—Urticaria—Hydrocortisone—rheumatoid arthritis	5.22e-05	0.000635	CcSEcCtD
Sulindac—Body temperature increased—Hydrocortisone—rheumatoid arthritis	5.19e-05	0.000632	CcSEcCtD
Sulindac—Convulsion—Prednisone—rheumatoid arthritis	5.19e-05	0.000632	CcSEcCtD
Sulindac—Hypertension—Prednisone—rheumatoid arthritis	5.17e-05	0.00063	CcSEcCtD
Sulindac—Chills—Methotrexate—rheumatoid arthritis	5.16e-05	0.000628	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	5.11e-05	0.000623	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	5.11e-05	0.000623	CcSEcCtD
Sulindac—Arthralgia—Prednisone—rheumatoid arthritis	5.1e-05	0.000621	CcSEcCtD
Sulindac—Myalgia—Prednisone—rheumatoid arthritis	5.1e-05	0.000621	CcSEcCtD
Sulindac—Feeling abnormal—Triamcinolone—rheumatoid arthritis	5.1e-05	0.000621	CcSEcCtD
Sulindac—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	5.09e-05	0.000619	CcSEcCtD
Sulindac—Alopecia—Methotrexate—rheumatoid arthritis	5.08e-05	0.000619	CcSEcCtD
Sulindac—Insomnia—Betamethasone—rheumatoid arthritis	5.08e-05	0.000618	CcSEcCtD
Sulindac—Insomnia—Dexamethasone—rheumatoid arthritis	5.08e-05	0.000618	CcSEcCtD
Sulindac—Diarrhoea—Cyclosporine—rheumatoid arthritis	5.06e-05	0.000616	CcSEcCtD
Sulindac—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	5.05e-05	0.000615	CcSEcCtD
Sulindac—Paraesthesia—Dexamethasone—rheumatoid arthritis	5.04e-05	0.000614	CcSEcCtD
Sulindac—Paraesthesia—Betamethasone—rheumatoid arthritis	5.04e-05	0.000614	CcSEcCtD
Sulindac—Discomfort—Prednisone—rheumatoid arthritis	5.04e-05	0.000613	CcSEcCtD
Sulindac—Hypersensitivity—Prednisolone—rheumatoid arthritis	4.96e-05	0.000603	CcSEcCtD
Sulindac—Dyspepsia—Dexamethasone—rheumatoid arthritis	4.94e-05	0.000602	CcSEcCtD
Sulindac—Dyspepsia—Betamethasone—rheumatoid arthritis	4.94e-05	0.000602	CcSEcCtD
Sulindac—Urticaria—Triamcinolone—rheumatoid arthritis	4.91e-05	0.000598	CcSEcCtD
Sulindac—Urticaria—Methylprednisolone—rheumatoid arthritis	4.9e-05	0.000597	CcSEcCtD
Sulindac—Dysgeusia—Methotrexate—rheumatoid arthritis	4.9e-05	0.000597	CcSEcCtD
Sulindac—Body temperature increased—Triamcinolone—rheumatoid arthritis	4.89e-05	0.000595	CcSEcCtD
Sulindac—Dizziness—Cyclosporine—rheumatoid arthritis	4.89e-05	0.000595	CcSEcCtD
Sulindac—Oedema—Prednisone—rheumatoid arthritis	4.89e-05	0.000595	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisone—rheumatoid arthritis	4.89e-05	0.000595	CcSEcCtD
Sulindac—Decreased appetite—Betamethasone—rheumatoid arthritis	4.88e-05	0.000594	CcSEcCtD
Sulindac—Decreased appetite—Dexamethasone—rheumatoid arthritis	4.88e-05	0.000594	CcSEcCtD
Sulindac—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	4.84e-05	0.000589	CcSEcCtD
Sulindac—Fatigue—Dexamethasone—rheumatoid arthritis	4.84e-05	0.000589	CcSEcCtD
Sulindac—Fatigue—Betamethasone—rheumatoid arthritis	4.84e-05	0.000589	CcSEcCtD
Sulindac—Shock—Prednisone—rheumatoid arthritis	4.81e-05	0.000586	CcSEcCtD
Sulindac—Tachycardia—Prednisone—rheumatoid arthritis	4.77e-05	0.000581	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisone—rheumatoid arthritis	4.72e-05	0.000575	CcSEcCtD
Sulindac—Vision blurred—Methotrexate—rheumatoid arthritis	4.72e-05	0.000574	CcSEcCtD
Sulindac—Asthenia—Hydrocortisone—rheumatoid arthritis	4.71e-05	0.000574	CcSEcCtD
Sulindac—Vomiting—Cyclosporine—rheumatoid arthritis	4.7e-05	0.000572	CcSEcCtD
Sulindac—Rash—Cyclosporine—rheumatoid arthritis	4.66e-05	0.000567	CcSEcCtD
Sulindac—Anorexia—Prednisone—rheumatoid arthritis	4.66e-05	0.000567	CcSEcCtD
Sulindac—Dermatitis—Cyclosporine—rheumatoid arthritis	4.66e-05	0.000567	CcSEcCtD
Sulindac—Pruritus—Hydrocortisone—rheumatoid arthritis	4.65e-05	0.000566	CcSEcCtD
Sulindac—Ill-defined disorder—Methotrexate—rheumatoid arthritis	4.64e-05	0.000565	CcSEcCtD
Sulindac—Headache—Cyclosporine—rheumatoid arthritis	4.63e-05	0.000564	CcSEcCtD
Sulindac—Anaemia—Methotrexate—rheumatoid arthritis	4.63e-05	0.000563	CcSEcCtD
Sulindac—Feeling abnormal—Betamethasone—rheumatoid arthritis	4.62e-05	0.000563	CcSEcCtD
Sulindac—Feeling abnormal—Dexamethasone—rheumatoid arthritis	4.62e-05	0.000563	CcSEcCtD
Sulindac—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	4.59e-05	0.000559	CcSEcCtD
Sulindac—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	4.59e-05	0.000559	CcSEcCtD
Sulindac—Hypersensitivity—Triamcinolone—rheumatoid arthritis	4.56e-05	0.000555	CcSEcCtD
Sulindac—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	4.55e-05	0.000554	CcSEcCtD
Sulindac—Malaise—Methotrexate—rheumatoid arthritis	4.51e-05	0.00055	CcSEcCtD
Sulindac—Vertigo—Methotrexate—rheumatoid arthritis	4.5e-05	0.000548	CcSEcCtD
Sulindac—Diarrhoea—Hydrocortisone—rheumatoid arthritis	4.49e-05	0.000547	CcSEcCtD
Sulindac—Leukopenia—Methotrexate—rheumatoid arthritis	4.48e-05	0.000546	CcSEcCtD
Sulindac—Urticaria—Betamethasone—rheumatoid arthritis	4.46e-05	0.000543	CcSEcCtD
Sulindac—Urticaria—Dexamethasone—rheumatoid arthritis	4.46e-05	0.000543	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	4.45e-05	0.000542	CcSEcCtD
Sulindac—Dizziness—Prednisolone—rheumatoid arthritis	4.45e-05	0.000542	CcSEcCtD
Sulindac—Asthenia—Triamcinolone—rheumatoid arthritis	4.44e-05	0.00054	CcSEcCtD
Sulindac—Body temperature increased—Betamethasone—rheumatoid arthritis	4.44e-05	0.00054	CcSEcCtD
Sulindac—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.44e-05	0.00054	CcSEcCtD
Sulindac—Asthenia—Methylprednisolone—rheumatoid arthritis	4.43e-05	0.000539	CcSEcCtD
Sulindac—Insomnia—Prednisone—rheumatoid arthritis	4.42e-05	0.000538	CcSEcCtD
Sulindac—Nausea—Cyclosporine—rheumatoid arthritis	4.39e-05	0.000535	CcSEcCtD
Sulindac—Paraesthesia—Prednisone—rheumatoid arthritis	4.39e-05	0.000534	CcSEcCtD
Sulindac—Pruritus—Triamcinolone—rheumatoid arthritis	4.38e-05	0.000533	CcSEcCtD
Sulindac—Pruritus—Methylprednisolone—rheumatoid arthritis	4.37e-05	0.000532	CcSEcCtD
Sulindac—Dizziness—Hydrocortisone—rheumatoid arthritis	4.34e-05	0.000529	CcSEcCtD
Sulindac—Convulsion—Methotrexate—rheumatoid arthritis	4.34e-05	0.000528	CcSEcCtD
Sulindac—Dyspepsia—Prednisone—rheumatoid arthritis	4.3e-05	0.000524	CcSEcCtD
Sulindac—Chest pain—Methotrexate—rheumatoid arthritis	4.26e-05	0.000519	CcSEcCtD
Sulindac—Arthralgia—Methotrexate—rheumatoid arthritis	4.26e-05	0.000519	CcSEcCtD
Sulindac—Myalgia—Methotrexate—rheumatoid arthritis	4.26e-05	0.000519	CcSEcCtD
Sulindac—Decreased appetite—Prednisone—rheumatoid arthritis	4.25e-05	0.000517	CcSEcCtD
Sulindac—Rash—Prednisolone—rheumatoid arthritis	4.24e-05	0.000516	CcSEcCtD
Sulindac—Dermatitis—Prednisolone—rheumatoid arthritis	4.24e-05	0.000516	CcSEcCtD
Sulindac—Diarrhoea—Methylprednisolone—rheumatoid arthritis	4.22e-05	0.000514	CcSEcCtD
Sulindac—Fatigue—Prednisone—rheumatoid arthritis	4.21e-05	0.000513	CcSEcCtD
Sulindac—Headache—Prednisolone—rheumatoid arthritis	4.21e-05	0.000513	CcSEcCtD
Sulindac—Discomfort—Methotrexate—rheumatoid arthritis	4.21e-05	0.000513	CcSEcCtD
Sulindac—Constipation—Prednisone—rheumatoid arthritis	4.18e-05	0.000509	CcSEcCtD
Sulindac—Vomiting—Hydrocortisone—rheumatoid arthritis	4.18e-05	0.000509	CcSEcCtD
Sulindac—Rash—Hydrocortisone—rheumatoid arthritis	4.14e-05	0.000504	CcSEcCtD
Sulindac—Dermatitis—Hydrocortisone—rheumatoid arthritis	4.14e-05	0.000504	CcSEcCtD
Sulindac—Headache—Hydrocortisone—rheumatoid arthritis	4.11e-05	0.000501	CcSEcCtD
Sulindac—Dizziness—Triamcinolone—rheumatoid arthritis	4.09e-05	0.000498	CcSEcCtD
Sulindac—Anaphylactic shock—Methotrexate—rheumatoid arthritis	4.08e-05	0.000497	CcSEcCtD
Sulindac—Dizziness—Methylprednisolone—rheumatoid arthritis	4.08e-05	0.000497	CcSEcCtD
Sulindac—Feeling abnormal—Prednisone—rheumatoid arthritis	4.03e-05	0.00049	CcSEcCtD
Sulindac—Asthenia—Betamethasone—rheumatoid arthritis	4.03e-05	0.00049	CcSEcCtD
Sulindac—Asthenia—Dexamethasone—rheumatoid arthritis	4.03e-05	0.00049	CcSEcCtD
Sulindac—Thrombocytopenia—Methotrexate—rheumatoid arthritis	4e-05	0.000487	CcSEcCtD
Sulindac—Gastrointestinal pain—Prednisone—rheumatoid arthritis	4e-05	0.000487	CcSEcCtD
Sulindac—Nausea—Prednisolone—rheumatoid arthritis	3.99e-05	0.000486	CcSEcCtD
Sulindac—Pruritus—Dexamethasone—rheumatoid arthritis	3.97e-05	0.000484	CcSEcCtD
Sulindac—Pruritus—Betamethasone—rheumatoid arthritis	3.97e-05	0.000484	CcSEcCtD
Sulindac—Hyperhidrosis—Methotrexate—rheumatoid arthritis	3.95e-05	0.000481	CcSEcCtD
Sulindac—Vomiting—Triamcinolone—rheumatoid arthritis	3.93e-05	0.000479	CcSEcCtD
Sulindac—Vomiting—Methylprednisolone—rheumatoid arthritis	3.92e-05	0.000478	CcSEcCtD
Sulindac—Nausea—Hydrocortisone—rheumatoid arthritis	3.9e-05	0.000475	CcSEcCtD
Sulindac—Rash—Triamcinolone—rheumatoid arthritis	3.9e-05	0.000475	CcSEcCtD
Sulindac—Dermatitis—Triamcinolone—rheumatoid arthritis	3.9e-05	0.000474	CcSEcCtD
Sulindac—Anorexia—Methotrexate—rheumatoid arthritis	3.89e-05	0.000474	CcSEcCtD
Sulindac—Rash—Methylprednisolone—rheumatoid arthritis	3.89e-05	0.000474	CcSEcCtD
Sulindac—Dermatitis—Methylprednisolone—rheumatoid arthritis	3.89e-05	0.000473	CcSEcCtD
Sulindac—Urticaria—Prednisone—rheumatoid arthritis	3.88e-05	0.000473	CcSEcCtD
Sulindac—Headache—Triamcinolone—rheumatoid arthritis	3.87e-05	0.000472	CcSEcCtD
Sulindac—Headache—Methylprednisolone—rheumatoid arthritis	3.87e-05	0.000471	CcSEcCtD
Sulindac—Body temperature increased—Prednisone—rheumatoid arthritis	3.86e-05	0.00047	CcSEcCtD
Sulindac—Diarrhoea—Dexamethasone—rheumatoid arthritis	3.84e-05	0.000468	CcSEcCtD
Sulindac—Diarrhoea—Betamethasone—rheumatoid arthritis	3.84e-05	0.000468	CcSEcCtD
Sulindac—Hypotension—Methotrexate—rheumatoid arthritis	3.82e-05	0.000465	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	3.72e-05	0.000453	CcSEcCtD
Sulindac—Dizziness—Dexamethasone—rheumatoid arthritis	3.71e-05	0.000452	CcSEcCtD
Sulindac—Dizziness—Betamethasone—rheumatoid arthritis	3.71e-05	0.000452	CcSEcCtD
Sulindac—Insomnia—Methotrexate—rheumatoid arthritis	3.69e-05	0.00045	CcSEcCtD
Sulindac—Nausea—Triamcinolone—rheumatoid arthritis	3.67e-05	0.000447	CcSEcCtD
Sulindac—Paraesthesia—Methotrexate—rheumatoid arthritis	3.67e-05	0.000447	CcSEcCtD
Sulindac—Nausea—Methylprednisolone—rheumatoid arthritis	3.67e-05	0.000446	CcSEcCtD
Sulindac—Dyspnoea—Methotrexate—rheumatoid arthritis	3.64e-05	0.000443	CcSEcCtD
Sulindac—Somnolence—Methotrexate—rheumatoid arthritis	3.63e-05	0.000442	CcSEcCtD
Sulindac—Hypersensitivity—Prednisone—rheumatoid arthritis	3.6e-05	0.000438	CcSEcCtD
Sulindac—Dyspepsia—Methotrexate—rheumatoid arthritis	3.6e-05	0.000438	CcSEcCtD
Sulindac—Vomiting—Betamethasone—rheumatoid arthritis	3.57e-05	0.000435	CcSEcCtD
Sulindac—Vomiting—Dexamethasone—rheumatoid arthritis	3.57e-05	0.000435	CcSEcCtD
Sulindac—Decreased appetite—Methotrexate—rheumatoid arthritis	3.55e-05	0.000432	CcSEcCtD
Sulindac—Rash—Betamethasone—rheumatoid arthritis	3.54e-05	0.000431	CcSEcCtD
Sulindac—Rash—Dexamethasone—rheumatoid arthritis	3.54e-05	0.000431	CcSEcCtD
Sulindac—Dermatitis—Betamethasone—rheumatoid arthritis	3.54e-05	0.00043	CcSEcCtD
Sulindac—Dermatitis—Dexamethasone—rheumatoid arthritis	3.54e-05	0.00043	CcSEcCtD
Sulindac—Fatigue—Methotrexate—rheumatoid arthritis	3.52e-05	0.000429	CcSEcCtD
Sulindac—Headache—Betamethasone—rheumatoid arthritis	3.52e-05	0.000428	CcSEcCtD
Sulindac—Headache—Dexamethasone—rheumatoid arthritis	3.52e-05	0.000428	CcSEcCtD
Sulindac—Asthenia—Prednisone—rheumatoid arthritis	3.51e-05	0.000427	CcSEcCtD
Sulindac—Pruritus—Prednisone—rheumatoid arthritis	3.46e-05	0.000421	CcSEcCtD
Sulindac—Feeling abnormal—Methotrexate—rheumatoid arthritis	3.37e-05	0.00041	CcSEcCtD
Sulindac—Diarrhoea—Prednisone—rheumatoid arthritis	3.34e-05	0.000407	CcSEcCtD
Sulindac—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	3.34e-05	0.000407	CcSEcCtD
Sulindac—Nausea—Dexamethasone—rheumatoid arthritis	3.33e-05	0.000406	CcSEcCtD
Sulindac—Nausea—Betamethasone—rheumatoid arthritis	3.33e-05	0.000406	CcSEcCtD
Sulindac—Urticaria—Methotrexate—rheumatoid arthritis	3.24e-05	0.000395	CcSEcCtD
Sulindac—Dizziness—Prednisone—rheumatoid arthritis	3.23e-05	0.000394	CcSEcCtD
Sulindac—Body temperature increased—Methotrexate—rheumatoid arthritis	3.23e-05	0.000393	CcSEcCtD
Sulindac—Vomiting—Prednisone—rheumatoid arthritis	3.11e-05	0.000378	CcSEcCtD
Sulindac—Rash—Prednisone—rheumatoid arthritis	3.08e-05	0.000375	CcSEcCtD
Sulindac—Dermatitis—Prednisone—rheumatoid arthritis	3.08e-05	0.000375	CcSEcCtD
Sulindac—Headache—Prednisone—rheumatoid arthritis	3.06e-05	0.000373	CcSEcCtD
Sulindac—Hypersensitivity—Methotrexate—rheumatoid arthritis	3.01e-05	0.000366	CcSEcCtD
Sulindac—Asthenia—Methotrexate—rheumatoid arthritis	2.93e-05	0.000357	CcSEcCtD
Sulindac—Nausea—Prednisone—rheumatoid arthritis	2.9e-05	0.000354	CcSEcCtD
Sulindac—Pruritus—Methotrexate—rheumatoid arthritis	2.89e-05	0.000352	CcSEcCtD
Sulindac—Diarrhoea—Methotrexate—rheumatoid arthritis	2.79e-05	0.00034	CcSEcCtD
Sulindac—Dizziness—Methotrexate—rheumatoid arthritis	2.7e-05	0.000329	CcSEcCtD
Sulindac—Vomiting—Methotrexate—rheumatoid arthritis	2.6e-05	0.000316	CcSEcCtD
Sulindac—Rash—Methotrexate—rheumatoid arthritis	2.58e-05	0.000314	CcSEcCtD
Sulindac—Dermatitis—Methotrexate—rheumatoid arthritis	2.57e-05	0.000313	CcSEcCtD
Sulindac—Headache—Methotrexate—rheumatoid arthritis	2.56e-05	0.000312	CcSEcCtD
Sulindac—Nausea—Methotrexate—rheumatoid arthritis	2.43e-05	0.000295	CcSEcCtD
Sulindac—CYP1A1—Metabolism—PLB1—rheumatoid arthritis	6.72e-06	7.02e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MAPK8—rheumatoid arthritis	6.68e-06	6.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CSF2—rheumatoid arthritis	6.67e-06	6.97e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TYK2—rheumatoid arthritis	6.65e-06	6.94e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MED1—rheumatoid arthritis	6.64e-06	6.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—rheumatoid arthritis	6.64e-06	6.94e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TLE3—rheumatoid arthritis	6.64e-06	6.93e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—BGN—rheumatoid arthritis	6.64e-06	6.93e-05	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	6.63e-06	6.93e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—POMC—rheumatoid arthritis	6.6e-06	6.89e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GC—rheumatoid arthritis	6.59e-06	6.89e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGES—rheumatoid arthritis	6.59e-06	6.89e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NCF2—rheumatoid arthritis	6.58e-06	6.87e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQB1—rheumatoid arthritis	6.53e-06	6.82e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	6.5e-06	6.79e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	6.44e-06	6.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SH2B3—rheumatoid arthritis	6.41e-06	6.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TRAF6—rheumatoid arthritis	6.41e-06	6.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GZMB—rheumatoid arthritis	6.37e-06	6.66e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PTK2—rheumatoid arthritis	6.31e-06	6.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—VDR—rheumatoid arthritis	6.3e-06	6.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	6.21e-06	6.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1A—rheumatoid arthritis	6.2e-06	6.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL18—rheumatoid arthritis	6.19e-06	6.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL3—rheumatoid arthritis	6.18e-06	6.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL2—rheumatoid arthritis	6.18e-06	6.46e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ACP5—rheumatoid arthritis	6.17e-06	6.45e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	6.17e-06	6.45e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—VEGFA—rheumatoid arthritis	6.17e-06	6.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD40LG—rheumatoid arthritis	6.16e-06	6.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—rheumatoid arthritis	6.14e-06	6.42e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PLB1—rheumatoid arthritis	6.13e-06	6.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCR5—rheumatoid arthritis	6.1e-06	6.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CSF2—rheumatoid arthritis	6.1e-06	6.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—rheumatoid arthritis	6.1e-06	6.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—rheumatoid arthritis	6.08e-06	6.35e-05	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	6.07e-06	6.34e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC11A1—rheumatoid arthritis	6.06e-06	6.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SAA1—rheumatoid arthritis	6.05e-06	6.32e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALB—rheumatoid arthritis	6.02e-06	6.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2RA—rheumatoid arthritis	6.01e-06	6.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—rheumatoid arthritis	6.01e-06	6.28e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NFATC1—rheumatoid arthritis	6.01e-06	6.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—C3—rheumatoid arthritis	5.96e-06	6.23e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AGER—rheumatoid arthritis	5.94e-06	6.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP9—rheumatoid arthritis	5.93e-06	6.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NCF1—rheumatoid arthritis	5.92e-06	6.19e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MED1—rheumatoid arthritis	5.89e-06	6.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NFKB1—rheumatoid arthritis	5.86e-06	6.13e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-B—rheumatoid arthritis	5.86e-06	6.13e-05	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	5.8e-06	6.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	5.8e-06	6.06e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PTK2—rheumatoid arthritis	5.79e-06	6.05e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NOS3—rheumatoid arthritis	5.75e-06	6.01e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	5.73e-06	5.99e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—rheumatoid arthritis	5.7e-06	5.95e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CD28—rheumatoid arthritis	5.7e-06	5.95e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NR3C1—rheumatoid arthritis	5.67e-06	5.93e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.67e-06	5.92e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TGFB1—rheumatoid arthritis	5.66e-06	5.91e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CSF2—rheumatoid arthritis	5.59e-06	5.84e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NCF2—rheumatoid arthritis	5.59e-06	5.84e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—BGN—rheumatoid arthritis	5.56e-06	5.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2RA—rheumatoid arthritis	5.49e-06	5.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ACP5—rheumatoid arthritis	5.48e-06	5.72e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—B3GNT2—rheumatoid arthritis	5.48e-06	5.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—C3—rheumatoid arthritis	5.45e-06	5.69e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-A—rheumatoid arthritis	5.43e-06	5.68e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MED1—rheumatoid arthritis	5.37e-06	5.61e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.36e-06	5.6e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—VEGFA—rheumatoid arthritis	5.32e-06	5.56e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTGS2—rheumatoid arthritis	5.26e-06	5.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.26e-06	5.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL12—rheumatoid arthritis	5.26e-06	5.49e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ENO1—rheumatoid arthritis	5.25e-06	5.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—VEGFA—rheumatoid arthritis	5.22e-06	5.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	5.22e-06	5.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6ST—rheumatoid arthritis	5.21e-06	5.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.2e-06	5.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CRP—rheumatoid arthritis	5.18e-06	5.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—NFKB1—rheumatoid arthritis	5.18e-06	5.41e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.17e-06	5.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—rheumatoid arthritis	5.16e-06	5.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CCR5—rheumatoid arthritis	5.15e-06	5.38e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SAA1—rheumatoid arthritis	5.14e-06	5.37e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	5.12e-06	5.34e-05	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	5.11e-06	5.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MAPK8—rheumatoid arthritis	5.09e-06	5.32e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2RA—rheumatoid arthritis	5.04e-06	5.27e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	5.04e-06	5.27e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTHFR—rheumatoid arthritis	5.03e-06	5.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NCF1—rheumatoid arthritis	5.03e-06	5.26e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—HLA-A—rheumatoid arthritis	5.02e-06	5.24e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—B3GNT2—rheumatoid arthritis	4.99e-06	5.22e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ACP5—rheumatoid arthritis	4.99e-06	5.22e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ENO1—rheumatoid arthritis	4.98e-06	5.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR4—rheumatoid arthritis	4.97e-06	5.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DRB1—rheumatoid arthritis	4.96e-06	5.19e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—BGN—rheumatoid arthritis	4.93e-06	5.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RASGRP1—rheumatoid arthritis	4.9e-06	5.12e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SYK—rheumatoid arthritis	4.89e-06	5.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—rheumatoid arthritis	4.88e-06	5.1e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	4.87e-06	5.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD28—rheumatoid arthritis	4.84e-06	5.05e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—MMP1—rheumatoid arthritis	4.81e-06	5.02e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.8e-06	5.01e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—rheumatoid arthritis	4.79e-06	5.01e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—POMC—rheumatoid arthritis	4.77e-06	4.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6ST—rheumatoid arthritis	4.76e-06	4.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ICAM1—rheumatoid arthritis	4.76e-06	4.98e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	4.74e-06	4.95e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT1—rheumatoid arthritis	4.71e-06	4.93e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL2—rheumatoid arthritis	4.67e-06	4.87e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—rheumatoid arthritis	4.66e-06	4.87e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6R—rheumatoid arthritis	4.65e-06	4.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL10—rheumatoid arthritis	4.65e-06	4.86e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	4.61e-06	4.82e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GC—rheumatoid arthritis	4.61e-06	4.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD80—rheumatoid arthritis	4.59e-06	4.79e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—rheumatoid arthritis	4.56e-06	4.77e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—UBE2D1—rheumatoid arthritis	4.55e-06	4.76e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALOX5—rheumatoid arthritis	4.54e-06	4.74e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.52e-06	4.72e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.5e-06	4.7e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—BGN—rheumatoid arthritis	4.5e-06	4.7e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	4.47e-06	4.67e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ADRBK1—rheumatoid arthritis	4.42e-06	4.61e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6ST—rheumatoid arthritis	4.4e-06	4.6e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—FN1—rheumatoid arthritis	4.39e-06	4.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS2—rheumatoid arthritis	4.36e-06	4.56e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS2—rheumatoid arthritis	4.34e-06	4.53e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	4.29e-06	4.48e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—rheumatoid arthritis	4.27e-06	4.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6R—rheumatoid arthritis	4.25e-06	4.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP3—rheumatoid arthritis	4.24e-06	4.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TYK2—rheumatoid arthritis	4.24e-06	4.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD80—rheumatoid arthritis	4.23e-06	4.42e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ENO1—rheumatoid arthritis	4.17e-06	4.36e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ALOX5—rheumatoid arthritis	4.14e-06	4.32e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.1e-06	4.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTK2—rheumatoid arthritis	4.08e-06	4.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PRKCQ—rheumatoid arthritis	4.08e-06	4.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT1—rheumatoid arthritis	4e-06	4.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL5—rheumatoid arthritis	4e-06	4.18e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.99e-06	4.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—rheumatoid arthritis	3.94e-06	4.12e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CSF2—rheumatoid arthritis	3.94e-06	4.12e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6R—rheumatoid arthritis	3.92e-06	4.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TYK2—rheumatoid arthritis	3.87e-06	4.04e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CAT—rheumatoid arthritis	3.78e-06	3.95e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MED1—rheumatoid arthritis	3.76e-06	3.93e-05	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—rheumatoid arthritis	3.72e-06	3.89e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SPP1—rheumatoid arthritis	3.71e-06	3.87e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ENO1—rheumatoid arthritis	3.7e-06	3.87e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.69e-06	3.85e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—rheumatoid arthritis	3.68e-06	3.85e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.64e-06	3.8e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.64e-06	3.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNG—rheumatoid arthritis	3.62e-06	3.79e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR5—rheumatoid arthritis	3.6e-06	3.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TYK2—rheumatoid arthritis	3.57e-06	3.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2RA—rheumatoid arthritis	3.55e-06	3.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—rheumatoid arthritis	3.53e-06	3.68e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—C3—rheumatoid arthritis	3.52e-06	3.68e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—rheumatoid arthritis	3.51e-06	3.67e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—rheumatoid arthritis	3.5e-06	3.66e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	3.49e-06	3.65e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	3.49e-06	3.65e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—rheumatoid arthritis	3.49e-06	3.64e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ENO1—rheumatoid arthritis	3.37e-06	3.52e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEP—rheumatoid arthritis	3.28e-06	3.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—rheumatoid arthritis	3.25e-06	3.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—rheumatoid arthritis	3.23e-06	3.38e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—rheumatoid arthritis	3.23e-06	3.38e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—rheumatoid arthritis	3.22e-06	3.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—rheumatoid arthritis	3.21e-06	3.35e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.18e-06	3.33e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	3.16e-06	3.3e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—BGN—rheumatoid arthritis	3.15e-06	3.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FN1—rheumatoid arthritis	3.09e-06	3.23e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6ST—rheumatoid arthritis	3.08e-06	3.22e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CCR5—rheumatoid arthritis	3.06e-06	3.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NFKB1—rheumatoid arthritis	3.02e-06	3.15e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAT—rheumatoid arthritis	3e-06	3.14e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—rheumatoid arthritis	2.99e-06	3.13e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HLA-A—rheumatoid arthritis	2.98e-06	3.12e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK8—rheumatoid arthritis	2.96e-06	3.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CD80—rheumatoid arthritis	2.96e-06	3.1e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—rheumatoid arthritis	2.96e-06	3.09e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.9e-06	3.03e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	2.89e-06	3.02e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—POMC—rheumatoid arthritis	2.82e-06	2.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—rheumatoid arthritis	2.76e-06	2.88e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6R—rheumatoid arthritis	2.75e-06	2.87e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAT—rheumatoid arthritis	2.66e-06	2.78e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6ST—rheumatoid arthritis	2.62e-06	2.73e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—rheumatoid arthritis	2.59e-06	2.71e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.55e-06	2.66e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—POMC—rheumatoid arthritis	2.52e-06	2.64e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD80—rheumatoid arthritis	2.52e-06	2.63e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—rheumatoid arthritis	2.51e-06	2.62e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	2.51e-06	2.62e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TYK2—rheumatoid arthritis	2.5e-06	2.61e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—rheumatoid arthritis	2.46e-06	2.57e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAT—rheumatoid arthritis	2.43e-06	2.54e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2.36e-06	2.47e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6R—rheumatoid arthritis	2.33e-06	2.44e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.32e-06	2.42e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—rheumatoid arthritis	2.32e-06	2.42e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—rheumatoid arthritis	2.31e-06	2.41e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—rheumatoid arthritis	2.3e-06	2.4e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—rheumatoid arthritis	2.22e-06	2.32e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—rheumatoid arthritis	2.2e-06	2.3e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.18e-06	2.28e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TYK2—rheumatoid arthritis	2.13e-06	2.22e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—rheumatoid arthritis	2.09e-06	2.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—rheumatoid arthritis	2.08e-06	2.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—rheumatoid arthritis	2.07e-06	2.16e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.03e-06	2.12e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—rheumatoid arthritis	2.03e-06	2.12e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	2.01e-06	2.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—POMC—rheumatoid arthritis	2e-06	2.09e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—rheumatoid arthritis	1.97e-06	2.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.95e-06	2.04e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—rheumatoid arthritis	1.92e-06	2.01e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.92e-06	2e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—rheumatoid arthritis	1.9e-06	1.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—rheumatoid arthritis	1.89e-06	1.98e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—rheumatoid arthritis	1.83e-06	1.91e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—POMC—rheumatoid arthritis	1.78e-06	1.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.77e-06	1.85e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—rheumatoid arthritis	1.75e-06	1.83e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—rheumatoid arthritis	1.75e-06	1.83e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.7e-06	1.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.62e-06	1.7e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—rheumatoid arthritis	1.62e-06	1.69e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—POMC—rheumatoid arthritis	1.62e-06	1.69e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—rheumatoid arthritis	1.55e-06	1.62e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—rheumatoid arthritis	1.42e-06	1.48e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.42e-06	1.48e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—rheumatoid arthritis	1.41e-06	1.48e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—rheumatoid arthritis	1.38e-06	1.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—rheumatoid arthritis	1.34e-06	1.4e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—rheumatoid arthritis	1.29e-06	1.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—rheumatoid arthritis	1.22e-06	1.28e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.13e-06	1.18e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—rheumatoid arthritis	1.04e-06	1.09e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—rheumatoid arthritis	1.03e-06	1.08e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	9.89e-07	1.03e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	9.04e-07	9.45e-06	CbGpPWpGaD
